Schapira on Breast Cancer and Survivorship

• How to Prepare Yourself for a Virtual ASCO Dr Lidia Schapira on how she and her colleagues are preparing to get as much out of the newly virtual meeting as possible.
  Medscape Oncology, May 22, 2020
  1
• 'Atlas' Uncovers Hidden Parts of Cancer Care We often overlook the crucial role that patients' family and friends play in their care. Dr Lidia Schapira shares a simple technique for ensuring that they're properly supported.
  Medscape Oncology, January 16, 2020
  1
• Genetic Testing in Breast Cancer: The Rules Are Changing In this interview, Lidia Schapira talks with Allison Kurian about cancer genetics in patients with or at risk for breast cancer.
  Medscape Oncology, September 05, 2019
• What Matters Most to Oncology Patients?   Lidia Schapira talks with Ethan Basch, a leading investigator of patient-reported outcomes, on better ways to track patients' symptoms.
  Medscape Oncology, July 22, 2019
• Cognitive-Behavioral Therapy Reduces Endocrine Tx Side Effects Cognitive-behavioral therapy may offer breast cancer patients an option to manage the side effects of adjuvant endocrine therapy, according to a new study.
  Medscape Oncology, April 10, 2019
  1
• T-DM1 Benefits 'Striking' in HER2+ Early Breast Cancer Lidia Schapira provides her perspective on a recent study of trastuzumab emtansine in residual invasive HER2+ breast cancer.
  Medscape Oncology, March 07, 2019
  1
• Neoadjuvant Palbociclib Plus Letrozole in Early Breast Cancer Lidia Schapira provides her perspective on a recent study of palbociclib plus letrozole as neoadjuvant therapy for postmenopausal women with ER-positive breast cancer.
  Medscape Oncology, March 07, 2019
• Helping Patients Manage the Anxiety Behind CPM Does contralateral prophylactic mastectomy reduce breast cancer survivors' anxiety over the long term?
  Medscape Oncology, January 17, 2019
  1
• Does CPM Reduce Breast Cancer Survivors' Anxiety? Dr Lidia Schapira discusses a unique study that prospectively analyzed worry, distress, and quality of life in a group of women who underwent contralateral prophylactic mastectomy.
  Medscape Oncology, September 28, 2018
• MONALEESA-3 Expands Endocrine Tx for Advanced Breast Cancer The MONALEESA-3 trial marks an important step forward for endocrine therapies for advanced breast cancer, argues Lidia Schapira.
  Medscape Oncology, September 19, 2018
• Ovarian Suppression 'Triumphant' in HR-Positive Breast Cancers Compelling data have demonstrated that ovarian suppression is beneficial for hormone-sensitive breast cancer. The question now: How to counsel and help patients remain on maintenance therapies.
  Medscape Oncology, August 30, 2018
  1
• Optimal Cancer Pain Management Means Understanding Pain Psychology Pain psychology expert Dr Beth Darnall discusses the highly influential role psychology has in the experience of pain and how clinicians can treat pain better.
  Medscape Oncology, July 30, 2018
  5
• Isolation and Burnout in Physician Culture: Innovative Solutions For almost 20 years, Dr Tait Shanafelt has studied the causes and effects of physician burnout. In this interview, he provides his insight on this serious issue.
  Medscape Oncology, May 29, 2018
  27
• Clinical Takeaways From the 2018 Cancer Survivorship Symposium Cancer Survivorship expert Lidia Schapira reflects on the most important topics presented at the 2018 Cancer Survivorship Symposium.
  Medscape Oncology, March 09, 2018
  1
• Intermittent Versus Continuous Extended Adjuvant Letrozole A new study supports the approach of 'pausing' letrozole treatment for patients whose previous adjuvant therapy included an aromatase inhibitor, argues Lidia Schapira.
  Medscape Oncology, March 06, 2018
  1
• Overprescribing Opioids After Surgery for Cancer Oncologists need to counsel patients more actively about postoperative pain and work collaboratively in multidisciplinary teams to avoid overprescribing opioids, argues Dr Lidia Schapira.
  Medscape Oncology, February 02, 2018
  1
• New Potential Drug Therapy for AI-Associated Arthralgia The anti-depressant duloxetine effectively reduced musculoskeletal symptoms early in the course of treatment with aromatase inhibitors for early-stage breast cancer.
  Medscape Oncology, December 15, 2017
  1
• 'Right' Endocrine Therapy a Question in Youngest BC Patients An analysis of the SOFT and TEXT trial results throws some light on the question of which endocrine therapy is best in young patients with breast cancer.
  Medscape Oncology, July 25, 2017
  1
• Breast Reconstruction Methods Not Considered Equal Dr Lidia Schapira discusses the first randomized trial that looks at women's reported quality of life after two methods of breast reconstruction: implant and autologous tissue reconstruction.
  Medscape Oncology, April 17, 2017
  9
• Breast Cancer Survivorship: Can We Get It Right? Providing essential care for 3 million US breast cancer survivors is challenging, prompting Dr Lidia Schapira to summarize new data on symptom management, risk assessment, and questionable therapies.
  Medscape Oncology, January 27, 2017
  1